Biotech · Private company
Poxel SA
Track this companyFree. Adds Poxel SA to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- PXL065Phase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- PXL770Phase 2 · Nonalcoholic Fatty LiverClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)PHASE2 · COMPLETED · started Sep 1, 2020ClinicalTrials.gov NCT04321343 · fetched Nov 12, 2026
- A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLDPHASE1 · COMPLETED · started Aug 1, 2019ClinicalTrials.gov NCT03950882 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLDPHASE2 · COMPLETED · started Mar 29, 2019ClinicalTrials.gov NCT03763877 · fetched Nov 12, 2026